Figure 5. Secreted TIMP-1 Mediates Crosstalk between HSC and HCC Cells.
(A) TIMP-1 mRNA levels in LX-2 cells. Cells were treated with EW-7197 (1 μM) in the presence or absence of TGF-β1 (2 ng/ml) for 24 h. HPRT was used as a reference. (B) TIMP-1 protein levels in CM. The GADPH level in an aliquot of total cell lysate was used as a reference. (C) mRNA expression levels of TIMP-1 in HCC patients from the Chen and Mas dataset from Oncomine (www.oncomine.com). (D) Effects of TIMP-1 on the proliferation of SK-HEP1 cells. Cells were treated with CM for 72 h. (E) Representative images (left) and densitometric analysis (right) of wound-healing assay of SK-HEP1 cells. Cells were treated with CM for 30 h. Scale bars: 200 μm. (F) Representative images (left) and densitometric analysis (right) of soft agar assay of SK-HEP1 cells. Cells were treated with CM for 24 h. After treatment, the cells were counted and placed in soft agar for colony assay to determine cell survival. ***p < 0.001 vs. untreated control and ###p < 0.001 vs. CM-treated control.